- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06386406
This is a Study to Evaluate a Pre-confectioned Plantar Insole for the Treatment of Plantar Heel Pain (TAP)
A Mono-centric Clinical Investigation to Evaluate Performance of a Pre-confectioned Plantar Insole for the Treatment of Plantar Heel Pain.
Patients affected by plantar heel pain will be asked to use a pre-confectioned plantar insole for one year.
The aim of the study is to assess if the insole under study allows the patient to reach a better mobility and a faster return to the normal everyday life.
Study Overview
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lugano, Switzerland, 6900
- Recruiting
- EOC
-
Contact:
- Martin Riegger, Dr.med
- Phone Number: +41 (0) 91 811 70 29
- Email: RicercaOrtopedia.ORL@eoc.ch
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Male and female adults
- Age ranging 18 to 70 years
- Patients with a history of at least 6 months of plantar fasciitis resistant to other conventional therapies
- Willingness and ability to participate in the trial
- Informed Consent signed by the subject
Exclusion Criteria:
- Diabetes mellitus not controlled pharmacologically
- Rheumatoid arthritis
- Previous foot surgery
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, general physical problem of the participant, etc.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: TAP insole
|
The patients will have to wear the TAP insole when walking during the everyday life activities. This plantar insole is not a custom-made insole but a pre-confectioned one because designed according to two parameters: shoe size and gender. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in pain severity according to visual analog scale
Time Frame: 3 months
|
The pain visual analog scale (VAS) is a validated, self-assessment scale in which patients rate their pain by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain." The pain VAS will be administered at baseline by the patient himself and at follow-ups. A negative change from baseline will indicate an improvement in VAS score and, therefore, in local pain. |
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in pain severity according to visual analog scale
Time Frame: 2 weeks, 6 weeks, 6 and 12 months.
|
The pain VAS scale is a validated, self-assessment scale in which patients rate their pain by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain." The pain VAS will be administered at baseline by the patient himself and at follow-ups. A negative change from baseline will indicate an improvement in VAS score and, therefore, in local pain. |
2 weeks, 6 weeks, 6 and 12 months.
|
Subjective functional recovery based on the Foot Function Index (FFI) score [
Time Frame: baseline, 2 and 6 weeks, and 3, 6, and 12 months
|
Foot function Index measures the impact of foot pathology on function in terms of pain, disability and activity restriction.
The FFI is a self-administered index consisting of 23 items divided into 3 sub-scales.
The patient will answer each question on a scale from 0 (best) to 10 (worst result), that best describes their foot over the past week.
The pain subcategory consists of 9 items and measures foot pain in different situations.
The disability subcategory consists of 9 items and measures difficulty performing functional activities because of foot problems.
The activity limitation subcategory consists of 5 items and measures limitations in activities because of foot problems.
Both total and subcategory scores are calculated.
|
baseline, 2 and 6 weeks, and 3, 6, and 12 months
|
Quality of life and foot general health through the assessment of the Foot Health Status Questionnaire (FHSQ)
Time Frame: baseline, 2 and 6 weeks, and 3, 6, and 12 months follow-up
|
The Foot Health Status Questionnaire (FHSQ) is a self-assessment and trustworthy instrument about health quality regarding specific foot health, initially developed to assess the results of surgical treatment of common foot diseases.
It is made of questions regarding foot health and its impact on quality of life.
There are 4 subscales: foot pain (4 questions), foot function (4 questions), footwear (3 questions), and general foot health (2 questions).
For the subscales of pain, function, and general foot health, there is a 5-point Likert scale of no problems, pain, or limitations to severe problems, pain, or limitations.
Responses to footwear questions are on a 5-point bipolar Likert scale from strongly disagree to strongly agree for statements regarding shoe fit, discomfort wearing shoes, and shoe wear available.
|
baseline, 2 and 6 weeks, and 3, 6, and 12 months follow-up
|
Patient satisfaction on a 0-10 numeric rating scale (NRS)
Time Frame: 2 weeks, 6 weeks,3, 6, and 12 months
|
self-assessment scale in which patients rate their satisfaction by making a handwritten mark from the lowest satisfaction (0 point) to the highest satisfaction (10 points)
|
2 weeks, 6 weeks,3, 6, and 12 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ORL-ORT-040
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Plantar Fascitis
-
Cairo UniversityNot yet recruiting
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...RecruitingPlantar FascitisItaly
-
Chinese University of Hong KongRecruiting
-
Istanbul Medeniyet UniversityNot yet recruiting
-
Chinese University of Hong KongRecruitingPlantar FascitisHong Kong
-
Stanford UniversityNot yet recruitingPlantar Fascitis
-
Hospital for Special Surgery, New YorkActive, not recruiting
-
Riphah International UniversityCompletedPlantar FascitisPakistan
-
Universidad Miguel Hernandez de ElcheFundación para el Fomento de la Investigación Sanitaria y Biomédica de la...Not yet recruitingPlantar FascitisSpain
-
Sultan Qaboos UniversityRecruitingPlantar FascitisOman
Clinical Trials on TAP insole
-
Staffordshire UniversityKing's College Hospital NHS TrustNot yet recruiting
-
Federal University of São PauloConselho Nacional de Desenvolvimento Científico e TecnológicoCompletedMorton Neuroma
-
Reckitt Benckiser Healthcare (UK) LimitedSynteractHCR Deutschland GmbHTerminatedMusculoskeletal PainUnited Kingdom
-
Fondazione Don Carlo Gnocchi OnlusCompletedParkinson DiseaseItaly
-
Rush University Medical CenterArthritis FoundationCompleted
-
Taipei Medical University WanFang HospitalNot yet recruiting
-
China Medical University HospitalUnknown
-
Wilfrid Laurier UniversityCompletedAccidental FallsCanada
-
University of IowaFoundation for Physical Medicine and RehabilitationCompleted
-
Federal University of São PauloConselho Nacional de Desenvolvimento Científico e TecnológicoCompletedChronic Nonspecific Low Back PainBrazil